A Ledda

4.0k total citations
93 papers, 1.7k citations indexed

About

A Ledda is a scholar working on Surgery, Hematology and Internal Medicine. According to data from OpenAlex, A Ledda has authored 93 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 18 papers in Hematology and 13 papers in Internal Medicine. Recurrent topics in A Ledda's work include Diagnosis and Treatment of Venous Diseases (15 papers), Venous Thromboembolism Diagnosis and Management (13 papers) and Multiple Myeloma Research and Treatments (7 papers). A Ledda is often cited by papers focused on Diagnosis and Treatment of Venous Diseases (15 papers), Venous Thromboembolism Diagnosis and Management (13 papers) and Multiple Myeloma Research and Treatments (7 papers). A Ledda collaborates with scholars based in Italy, United States and Germany. A Ledda's co-authors include Mark Dugall, M R Cesarone, Gianni Belcaro, Giorgio La Nasa, Masako Hosoi, L Pellegrini, E. Ippolito, Stefano Togni, Stefano Stuard and A. Ricci and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

A Ledda

88 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Ledda Italy 25 479 391 322 260 201 93 1.7k
Hiroaki Yoshida Japan 29 283 0.6× 1.2k 3.1× 148 0.5× 289 1.1× 259 1.3× 115 3.2k
Francesca Oliviero Italy 31 307 0.6× 779 2.0× 52 0.2× 450 1.7× 251 1.2× 131 2.9k
Kazuhide Ohta Japan 23 345 0.7× 1.5k 3.9× 94 0.3× 259 1.0× 194 1.0× 67 2.5k
İsmail Koçyiğit Türkiye 22 136 0.3× 227 0.6× 62 0.2× 212 0.8× 54 0.3× 145 1.6k
Gerry T. M. Wagenaar Netherlands 29 197 0.4× 1.1k 2.9× 96 0.3× 549 2.1× 92 0.5× 61 2.5k
A F Suffredini United States 15 103 0.2× 398 1.0× 35 0.1× 248 1.0× 120 0.6× 23 2.2k
Qianqian Liu China 26 36 0.1× 702 1.8× 51 0.2× 195 0.8× 107 0.5× 137 2.0k
Emel Ekşioğlu Türkiye 30 338 0.7× 558 1.4× 105 0.3× 357 1.4× 103 0.5× 93 2.5k
Giuseppe Bianco Italy 25 69 0.1× 400 1.0× 86 0.3× 451 1.7× 88 0.4× 87 2.0k
Ulf Sibelius Germany 28 89 0.2× 450 1.2× 94 0.3× 216 0.8× 74 0.4× 68 2.4k

Countries citing papers authored by A Ledda

Since Specialization
Citations

This map shows the geographic impact of A Ledda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Ledda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Ledda more than expected).

Fields of papers citing papers by A Ledda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Ledda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Ledda. The network helps show where A Ledda may publish in the future.

Co-authorship network of co-authors of A Ledda

This figure shows the co-authorship network connecting the top 25 collaborators of A Ledda. A scholar is included among the top collaborators of A Ledda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Ledda. A Ledda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cappai, Stefano, Federica Loi, Giantonella Puggioni, et al.. (2024). First Detection of West Nile Virus by Nasopharyngeal Swab, Followed by Phylogenetic Analysis. Pathogens. 13(11). 1023–1023.
2.
Ledda, A, et al.. (2024). A survey on unsharp orthomodular lattices: A unifying framework. UNICA IRIS Institutional Research Information System (University of Cagliari). 5(1). 19–33.
4.
Hu, Shenqiang, G Belcaro, Mark Dugall, et al.. (2018). Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®).. PubMed. 22(15). 5042–5046. 13 indexed citations
5.
Sanna, Marco, Giovanni Caocci, A Ledda, et al.. (2017). Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia. Leukemia & lymphoma. 58(11). 2558–2564. 6 indexed citations
6.
Ledda, A, G Belcaro, Mark Dugall, et al.. (2017). A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study.. PubMed. 21(18). 4196–4202. 8 indexed citations
7.
Belcaro, G, Mark Dugall, Shen Hu, et al.. (2015). Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.. PubMed. 57(3). 121–5. 5 indexed citations
8.
Ledda, A, Antonio Bottari, R Luzzi, et al.. (2015). Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study.. PubMed. 19(1). 77–80. 19 indexed citations
9.
Kowalski, Tomasz, A Ledda, & Francesco Paoli. (2014). Quasi-subtractive varieties: Open filters, congruences and the commutator. Logic Journal of IGPL. 22(6). 844–871.
10.
Ledda, A, Gianni Belcaro, Mark Dugall, et al.. (2012). Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study.. PubMed. 54(1 Suppl 4). 17–22. 38 indexed citations
11.
Belcaro, G, Giovanni B. Agus, Cesarone Mr, et al.. (2011). Gore external valve support for superficial saphenous vein incompetence: a 10-year, follow-up registry.. PubMed. 53(3 Suppl 1). 35–41. 4 indexed citations
12.
Belcaro, Gianni, M R Cesarone, Mark Dugall, et al.. (2011). Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study.. PubMed. 53(3 Suppl 1). 3–11. 14 indexed citations
13.
Belcaro, Gianni, B.M. Errichi, Mark Dugall, et al.. (2010). Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment.. PubMed. 52(2 Suppl 1). 37–42. 17 indexed citations
14.
Belcaro, Gianni, M R Cesarone, Silvia Errichi, et al.. (2008). Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol®. Redox Report. 13(6). 271–276. 37 indexed citations
15.
Cesarone, M R, Gianni Belcaro, Silvia Errichi, et al.. (2007). Topical Heparin: New Observations. Angiology. 58(1S). 16S–20S. 4 indexed citations
16.
Belcaro, Gianni, M R Cesarone, B.M. Errichi, et al.. (2006). Diabetic Ulcers: Microcirculatory Improvement and Faster Healing With Pycnogenol. Clinical and Applied Thrombosis/Hemostasis. 12(3). 318–323. 33 indexed citations
18.
Nasa, Giorgio La, Alessandra Vacca, A Ledda, et al.. (1997). Role of HLA extended haplotypes in unrelated bone marrow transplantation. Bone Marrow Transplantation. 19. 186–189. 2 indexed citations
19.
Vacca, Alessandra, Carlo Carcassi, Giorgio La Nasa, et al.. (1994). Identification of two different HLA B49 DR4 extended haplotypes in the Sardinian population. Tissue Antigens. 43(2). 65–70. 2 indexed citations
20.
Espósito, Anthony P. & A Ledda. (1969). [Hysteroscopy: technic and clinical applications].. PubMed. 72(2). 155–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026